{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:58:07Z","timestamp":1790452687789,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10928-026-10066-3","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:11:59Z","timestamp":1790449919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of two model-based Bayesian approaches for vancomycin dosing in general hospitalized patients"],"prefix":"10.1007","volume":"53","author":[{"given":"Athar Salah","family":"Al-Khirbash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Al","family":"Za\u2019abi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhaina Salim","family":"Al-Maqbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabariah Noor","family":"Harun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Maisharah","family":"Sheikh Ghadzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"10066_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40262-019-00813-w","volume":"59","author":"SJF Hartman","year":"2020","unstructured":"Hartman SJF, Br\u00fcggemann RJ, Orri\u00ebns L, Dia N, Schreuder MF, de Wildt SN (2020) Pharmacokinetics and target attainment of antibiotics in critically ill children: a systematic review of current literature. Clin Pharmacokinet 59:173\u2013205. https:\/\/doi.org\/10.1007\/s40262-019-00813-w","journal-title":"Clin Pharmacokinet"},{"key":"10066_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/org6030028","volume":"6","author":"R Cartes-Vel\u00e1squez","year":"2025","unstructured":"Cartes-Vel\u00e1squez R, Morales-Le\u00f3n F, Valdebenito-Maturana F, S\u00e1ez-Riquelme P, Rodr\u00edguez-Ort\u00edz N, Carrillo-Bestagno H (2025) Structural innovations in vancomycin: overcoming resistance and expanding the antibacterial spectrum. Organics 6:28. https:\/\/doi.org\/10.3390\/org6030028","journal-title":"Organics"},{"key":"10066_CR3","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1086\/491712","volume":"42","author":"MJ Rybak","year":"2006","unstructured":"Rybak MJ (2006) The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin. Clin Infect Dis 42:S35\u2013S39. https:\/\/doi.org\/10.1086\/491712","journal-title":"Clin Infect Dis"},{"key":"10066_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5005\/jp-journals-10081-1387","volume":"5","author":"B Shenoy","year":"2023","unstructured":"Shenoy B, Joshi DN, Doddikoppad P (2023) Vancomycin Therapeutic Drug Monitoring. Pediatr Infect Disease 5:17\u201319. https:\/\/doi.org\/10.5005\/jp-journals-10081-1387","journal-title":"Pediatr Infect Disease"},{"key":"10066_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM (2020) Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 77:835\u2013864. https:\/\/doi.org\/10.1093\/ajhp\/zxaa036","journal-title":"Am J Health Syst Pharm"},{"key":"10066_CR6","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/cpt.2202","volume":"109","author":"SG Wicha","year":"2021","unstructured":"Wicha SG, M\u00e4rtson A, Nielsen EI, Koch BCP, Friberg LE, Alffenaar J, Minichmayr IK, the International Society of Anti-Infective Pharmacology (ISAP), the PK\/PD study group of the European Society of Clinical Microbiology, Infectious Diseases (EPASG) (2021) From therapeutic drug monitoring to model\u2010informed precision dosing for antibiotics. Clin Pharmacol Ther 109:928\u2013941. https:\/\/doi.org\/10.1002\/cpt.2202","journal-title":"Clin Pharmacol Ther"},{"key":"10066_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115421","volume":"215","author":"IK Minichmayr","year":"2024","unstructured":"Minichmayr IK, Dreesen E, Centanni M, Wang Z, Hoffert Y, Friberg LE, Wicha SG (2024) Model-informed precision dosing: state of the art and future perspectives. Adv Drug Deliv Rev 115421. https:\/\/doi.org\/10.1016\/j.addr.2024.115421","journal-title":"Adv Drug Deliv Rev"},{"key":"10066_CR8","doi-asserted-by":"publisher","first-page":"e01026","DOI":"10.1002\/prp2.1026","volume":"10","author":"A Chen","year":"2022","unstructured":"Chen A, Gupta A, Do DH, Nazer LH (2022) Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring. Pharmacol Res Perspect 10:e01026. https:\/\/doi.org\/10.1002\/prp2.1026","journal-title":"Pharmacol Res Perspect"},{"key":"10066_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7011376","volume":"2022","author":"AE Patanwala","year":"2022","unstructured":"Patanwala AE, Spremo D, Jeon M, Thoma Y, Alffenaar C, Stocker J-W S (2022) Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill. Crit Care Res Pract 2022:1\u20137. https:\/\/doi.org\/10.1155\/2022\/7011376","journal-title":"Crit Care Res Pract"},{"key":"10066_CR10","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","volume":"28","author":"AD Bai","year":"2022","unstructured":"Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, Tandon P, Senecal J, Del Corpo O, Stefanova I, Fogarty C, Butler-Laporte G, McDonald EG, Cheng MP, Morris AM, Loeb M, Lee TC (2022) Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clin Microbiol Infect 28:1076\u20131084. https:\/\/doi.org\/10.1016\/j.cmi.2022.03.015","journal-title":"Clin Microbiol Infect"},{"key":"10066_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/antibiotics12020301","volume":"12","author":"M Mena","year":"2023","unstructured":"Mena M, Garcia J-C, Bustos R-H (2023) Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients. Antibiotics 12:301. https:\/\/doi.org\/10.3390\/antibiotics12020301","journal-title":"Antibiotics"},{"key":"10066_CR12","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1111\/bcp.14360","volume":"86","author":"R ter Heine","year":"2020","unstructured":"ter Heine R, Keizer RJ, van Steeg K, Smolders EJ, van Luin M, Derijks HJ, de Jager CPC, Frenzel T, Br\u00fcggemann R (2020) Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients. Br J Clin Pharmacol 86:2497\u20132506. https:\/\/doi.org\/10.1111\/bcp.14360","journal-title":"Br J Clin Pharmacol"},{"key":"10066_CR13","doi-asserted-by":"publisher","first-page":"e952","DOI":"10.1097\/CCM.0000000000005062","volume":"49","author":"SW Narayan","year":"2021","unstructured":"Narayan SW, Thoma Y, Drennan PG, Kim HY, Alffenaar J-W, Van Hal S, Patanwala AE (2021) Predictive performance of Bayesian vancomycin monitoring in the critically ill*. Crit Care Med 49:e952\u2013e960. https:\/\/doi.org\/10.1097\/CCM.0000000000005062","journal-title":"Crit Care Med"},{"key":"10066_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cmi.2020.07.005","volume":"27","author":"CB Cunio","year":"2021","unstructured":"Cunio CB, Uster DW, Carland JE, Buscher H, Liu Z, Brett J, Stefani M, Jones GRD, Day RO, Wicha SG, Stocker SL (2021) Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients. Clin Microbiol Infect 27:783. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.005","journal-title":"Clin Microbiol Infect"},{"key":"10066_CR15","doi-asserted-by":"publisher","first-page":"1286.e1","DOI":"10.1016\/j.cmi.2019.02.029","volume":"25","author":"A Broeker","year":"2019","unstructured":"Broeker A, Nardecchia M, Klinker KP, Derendorf H, Day RO, Marriott DJ, Carland JE, Stocker SL, Wicha SG (2019) Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting. Clin Microbiol Infect 25:1286.e1-1286.e7. https:\/\/doi.org\/10.1016\/j.cmi.2019.02.029","journal-title":"Clin Microbiol Infect"},{"key":"10066_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/phar.2941","volume":"44","author":"A Duong","year":"2024","unstructured":"Duong A, El Gamal A, Bilodeau V, Huot J, Delorme C, Poudrette J, Crevier B, Marsot A (2024) Vancomycin: an analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population. Pharmacotherapy 44:425\u2013434. https:\/\/doi.org\/10.1002\/phar.2941","journal-title":"Pharmacotherapy"},{"key":"10066_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1128\/AAC.32.6.848","volume":"32","author":"KA Rodvold","year":"1988","unstructured":"Rodvold KA, Blum RA, Fischer JH, Zokufa HZ, Rotschafer JC, Crossley KB, Riff LJ (1988) Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother 32:848\u2013852. https:\/\/doi.org\/10.1128\/AAC.32.6.848","journal-title":"Antimicrob Agents Chemother"},{"key":"10066_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/FTD.0000000000000490","volume":"40","author":"V Goti","year":"2018","unstructured":"Goti V, Chaturvedula A, Fossler MJ, Mok S, Jacob JT (2018) Hospitalized patients with and without hemodialysis have markedly different vancomycin pharmacokinetics: a population pharmacokinetic model-based analysis. Ther Drug Monit 40:212\u2013221. https:\/\/doi.org\/10.1097\/FTD.0000000000000490","journal-title":"Ther Drug Monit"},{"key":"10066_CR19","unstructured":"Goti V (2018) Application Of Population Pharmacokinetic Modeling And Simulation In Anti-infective Therapy"},{"key":"10066_CR20","doi-asserted-by":"publisher","unstructured":"Madadizadeh F, Bahariniya S (2026) A Tutorial on Sample Size Calculation for Inter-rater and Intra-rater Agreement Studies. Indian J Psychol Med 02537176261422290. https:\/\/doi.org\/10.1177\/02537176261422290","DOI":"10.1177\/02537176261422290"},{"key":"10066_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/healthcare11030362","volume":"11","author":"AM Alzahrani","year":"2023","unstructured":"Alzahrani AM, Naeem A, Alzhrani RM, Harbi MA, Alghamdi SA, Karim S, Ali AS, Alsenaini G, Hasan H, Alkatheeri AA, Basudan SS, Alzahrani YA (2023) The Bayesian-Based Area under the Curve of Vancomycin by Using a Single Trough Level: An Evaluation of Accuracy and Discordance at Tertiary Care Hospital in KSA. Healthcare 11:362. https:\/\/doi.org\/10.3390\/healthcare11030362","journal-title":"Healthcare"},{"key":"10066_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H (2018) User\u2019s guide to correlation coefficients. Turk J Emerg Med 18:91\u201393. https:\/\/doi.org\/10.1016\/j.tjem.2018.08.001","journal-title":"Turk J Emerg Med"},{"key":"10066_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The Measurement of Observer Agreement for Categorical Data. Biometrics 33:159\u2013174. https:\/\/doi.org\/10.2307\/2529310","journal-title":"Biometrics"},{"key":"10066_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF01060893","volume":"9","author":"LB Sheiner","year":"1981","unstructured":"Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9:503\u2013512. https:\/\/doi.org\/10.1007\/BF01060893","journal-title":"J Pharmacokinet Biopharm"},{"key":"10066_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/cpt1979263294","volume":"26","author":"LB Sheiner","year":"1979","unstructured":"Sheiner LB, Beal S, Rosenberg B, Marathe VV (1979) Forecasting individual pharmacokinetics. Clin Pharmacol Ther 26:294\u2013305. https:\/\/doi.org\/10.1002\/cpt1979263294","journal-title":"Clin Pharmacol Ther"},{"key":"10066_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jointm.2023.12.007","volume":"4","author":"C Roger","year":"2024","unstructured":"Roger C (2024) Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review. J Intensive Med 4:287\u2013298. https:\/\/doi.org\/10.1016\/j.jointm.2023.12.007","journal-title":"J Intensive Med"},{"key":"10066_CR27","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s40262-024-01425-9","volume":"63","author":"BC Agema","year":"2024","unstructured":"Agema BC, Kocher T, \u00d6zt\u00fcrk AB, Giraud EL, van Erp NP, de Winter BCM, Mathijssen RHJ, Koolen SLW, Koch BCP, Sassen SDT (2024) Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling. Clin Pharmacokinet 63:1449\u20131461. https:\/\/doi.org\/10.1007\/s40262-024-01425-9","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10066-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:12:01Z","timestamp":1790449921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-026-10066-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10066"],"URL":"https:\/\/doi.org\/10.1007\/s10928-026-10066-3","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"14 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was obtained from the Medical and Research Ethics Committee of Sultan Qaboos University (SQU), (MREC#3455; SQU-EC\/247\/2024) and Jawatankuasa Etika Penyelidikan Manusia Universiti Sains Malaysia (JEPeM), Universiti Sains Malaysia (USM) (USM\/JEPeM\/PP\/25100862). Informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial interests.","order":2,"name":"Ethics","label":"Financial interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"58"}}